Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
23 Jun 2022
Historique:
received: 28 02 2022
revised: 14 05 2022
accepted: 18 05 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Hydrogen sulfide (H

Identifiants

pubmed: 35807290
pii: molecules27134049
doi: 10.3390/molecules27134049
pmc: PMC9268373
pii:
doi:

Substances chimiques

Cystathionine 375YFJ481O
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1
Cystathionine beta-Synthase EC 4.2.1.22
Cystathionine gamma-Lyase EC 4.4.1.1
Hydrogen Sulfide YY9FVM7NSN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Histopathology. 2011 Jun;58(7):1054-63
pubmed: 21707707
Anticancer Agents Med Chem. 2022;22(4):731-746
pubmed: 34645380
J Ethnopharmacol. 2021 Sep 15;277:114057
pubmed: 33771643
Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:30-45
pubmed: 35307285
Br J Pharmacol. 2013 Jun;169(4):922-32
pubmed: 23488457
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33431651
Front Pharmacol. 2020 Nov 19;11:564281
pubmed: 33364941
Am J Hypertens. 2012 Jan;25(1):74-81
pubmed: 21866187
Cancer Manag Res. 2021 Mar 02;13:2125-2129
pubmed: 33688255
Acta Pharmacol Sin. 2022 Jul;43(7):1829-1842
pubmed: 34795411
Molecules. 2018 Nov 08;23(11):
pubmed: 30413008
Nat Rev Clin Oncol. 2013 Mar;10(3):143-53
pubmed: 23400000
Front Pharmacol. 2020 Nov 30;11:585860
pubmed: 33390956
Chem Rev. 2018 Feb 14;118(3):1253-1337
pubmed: 29112440
Cancer Lett. 2019 Dec 1;466:49-60
pubmed: 31542354
Biomolecules. 2021 Jul 21;11(8):
pubmed: 34439739
BMC Cancer. 2018 Oct 1;18(1):939
pubmed: 30285678
Cell Mol Gastroenterol Hepatol. 2017 Nov 22;5(3):209-221
pubmed: 29379856
Int J Mol Sci. 2015 Jan 28;16(2):2942-55
pubmed: 25636036
Front Pharmacol. 2020 Jul 07;11:976
pubmed: 32774302
EMBO J. 2001 Aug 1;20(15):3910-6
pubmed: 11483494
J Biol Chem. 2009 Jan 30;284(5):3076-3085
pubmed: 19019829
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Adv Res. 2020 Feb 26;27:19-30
pubmed: 33318863
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
J Cell Mol Med. 2020 Jul;24(14):8221-8235
pubmed: 32548978
Front Microbiol. 2021 Jun 30;12:653562
pubmed: 34276590
Cancer Lett. 2018 Nov 1;436:119-128
pubmed: 30118845
Int J Mol Sci. 2020 Dec 26;22(1):
pubmed: 33375317
Front Oncol. 2020 Dec 08;10:613470
pubmed: 33364200
Adv Mater. 2020 May;32(19):e1906580
pubmed: 32250001
Pathophysiology. 2021 Sep 20;28(3):437-456
pubmed: 35366284
Cells. 2021 Jan 22;10(2):
pubmed: 33499368
J Biomol Struct Dyn. 2022 Jan;40(1):484-498
pubmed: 32876526
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
J Cancer. 2020 Jan 20;11(7):1828-1838
pubmed: 32194794
Am J Physiol Cell Physiol. 2020 Oct 1;319(4):C720-C733
pubmed: 32813542
BMC Cancer. 2016 Sep 21;16(1):742
pubmed: 27654866
Clin Cancer Res. 2007 Jul 1;13(13):3868-74
pubmed: 17606719
J Natl Cancer Inst. 2010 Dec 15;102(24):1874-8
pubmed: 21098759
Nat Rev Immunol. 2016 Jan;16(1):7-21
pubmed: 26655628
Nat Rev Clin Oncol. 2018 May;15(5):273-291
pubmed: 29508857
J Biol Chem. 2013 Jul 5;288(27):20002-13
pubmed: 23698001
Nat Rev Mol Cell Biol. 2012 Jul 11;13(8):499-507
pubmed: 22781905
Expert Rev Clin Pharmacol. 2011 Jan;4(1):13-32
pubmed: 22115346
Sci Rep. 2017 Jul 11;7(1):5134
pubmed: 28698660
J Ethnopharmacol. 2022 Jan 30;283:114751
pubmed: 34662662
Semin Cancer Biol. 2021 Jan;68:8-20
pubmed: 31550502
Pharmacol Res. 2021 Mar;165:105393
pubmed: 33484818
Sci Rep. 2021 Jan 15;11(1):1594
pubmed: 33452398
Biochem Pharmacol. 2020 Feb;172:113775
pubmed: 31870768
Int J Biol Sci. 2021 Jan 1;17(1):73-88
pubmed: 33390834
Cell. 2015 Jan 15;160(1-2):132-44
pubmed: 25542313
Nitric Oxide. 2015 Sep 15;49:26-39
pubmed: 26068241
J Cancer. 2019 Apr 3;10(7):1693-1706
pubmed: 31205525
Biochem Pharmacol. 2018 Mar;149:174-185
pubmed: 29061341
Cancer Lett. 2019 Jul 28;455:60-72
pubmed: 31042588
Signal Transduct Target Ther. 2021 Feb 8;6(1):52
pubmed: 33558454
Nat Rev Cancer. 2020 Aug;20(8):417-436
pubmed: 32528185
Cytometry A. 2019 Apr;95(4):381-388
pubmed: 30556331
Neurooncol Adv. 2021 Apr 09;3(1):vdab057
pubmed: 34250481
Science. 2008 Oct 24;322(5901):587-90
pubmed: 18948540
Brain Sci. 2020 Jan 06;10(1):
pubmed: 31935960
Oxid Med Cell Longev. 2021 Apr 17;2021:5599997
pubmed: 33953830
Nat Rev Drug Discov. 2014 Feb;13(2):140-56
pubmed: 24481312

Auteurs

Nazeer Hussain Khan (NH)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
School of Life Sciences, Henan University, Kaifeng 475004, China.

Di Wang (D)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.

Wenkang Wang (W)

Department of Breast Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.

Muhammad Shahid (M)

Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.

Saadullah Khattak (S)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
School of Life Sciences, Henan University, Kaifeng 475004, China.

Ebenezeri Erasto Ngowi (EE)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Department of Biological Sciences, Faculty of Science, Dar es Salaam University College of Education, Dar es Salaam 11101, Tanzania.

Muhammad Sarfraz (M)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Faculty of Pharmacy, The University of Lahore, Lahore 54590, Pakistan.

Xin-Ying Ji (XY)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
Kaifeng Key Laboratory of Infection and Biological Safety, College of Medicine, Henan University, Kaifeng 475004, China.

Chun-Yang Zhang (CY)

Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Department of General Thoracic Surgery, Hami Central Hospital, Hami 839000, China.

Dong-Dong Wu (DD)

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
School of Stomatology, Henan University, Kaifeng 475004, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH